We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 51

Apotex v. Pfizer
  • Gowling WLG
  • Canada
  • July 27 2009

The Court dismissed a motion by Pfizer for summary judgment in a s.8 proceeding


Canada v. Pharmascience
  • Gowling WLG
  • Canada
  • July 27 2009

The Court of Appeal upheld the decision of the trial judge holding that the generic company was not required to address the patents listed on the patent register against submissions filed after it had purchased its comparator drug


Apotex v. Janssen
  • Gowling WLG
  • Canada
  • July 27 2009

The Court of Appeal overturned the decision of the applications judge in issuing a prohibition order and sent it back for reconsideration


Epicept v. Minister of Health; interlocutory motion for confidentiality; histamine
  • Gowling WLG
  • Canada
  • February 12 2010

Epicept has filed for a judicial review of the Minister's decision that its histamine dihydrochloride product is not an innovative drug and is thus not eligible for listing on the register of innovative drugs


Janssen-Ortho v. Novopharm; merits of 55.2 proceeding; methylphenidate
  • Gowling WLG
  • Canada
  • February 12 2010

The only issue in this proceeding was an allegation of non-infringement and the application for prohibition was dismissed


Eli Lilly Canada Inc. v. Apotex; application to declare NOA null and void
  • Gowling WLG
  • Canada
  • November 2 2009

Apotex sent a NOA regarding the validity of a patent list on the Patent Register for an orally disintegrating tablet form of a drug


Sanofi-Aventis v. Novopharm; preliminary questions regarding costs assessment
  • Gowling WLG
  • Canada
  • November 2 2009

Sanofi had brought a proceeding against Novopharm and joined Schering as the respondentpatentee pursuant to the NOC Regulations


Sanofi-Aventis v. Canada; PMPRB decision
  • Gowling WLG
  • Canada
  • November 2 2009

Sanofi was seeking judicial review of an interlocutory decision of the Board, which was made during the course of dealings that had lasted a number of years


Apotex & Novopharm v. Wellcome; interlocutory motion to amend pleadings
  • Gowling WLG
  • Canada
  • November 2 2009

The Trial Division upheld the decision of the Prothonotary to allow GSK to amend its pleadings revising the quantum of damages sought in the proceeding


Eli Lilly v. Novopharm; merits of an infringement proceeding
  • Gowling WLG
  • Canada
  • November 2 2009

After a trial on the merits, the Court found that the patent at issue was invalid as it is not a valid selection patent